{
    "2018-08-08": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：国家医保局：新一轮抗癌药医保准入谈判下月完成",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国家医保局",
                        "抗癌药",
                        "医保准入",
                        "谈判"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报2018第29期:政策强化行业监管,把握估值与业绩",
                "features": {
                    "keywords": [
                        "医药行业",
                        "政策",
                        "行业监管",
                        "估值",
                        "业绩"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}